iodine has been researched along with Minimal Disease, Residual in 5 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
| Excerpt | Relevance | Reference |
|---|---|---|
| "Radioiodine ((131)I) therapy is used in patients with papillary and follicular thyroid carcinoma for ablation of thyroid remnants and for treatment of persistent or recurrent disease." | 8.81 | Radioiodine therapy for papillary and follicular thyroid carcinoma. ( Baudin, E; Klain, M; Leboulleux, S; Ricard, M; Schlumberger, M, 2002) |
| "Radioiodine ((131)I) therapy is used in patients with papillary and follicular thyroid carcinoma for ablation of thyroid remnants and for treatment of persistent or recurrent disease." | 4.81 | Radioiodine therapy for papillary and follicular thyroid carcinoma. ( Baudin, E; Klain, M; Leboulleux, S; Ricard, M; Schlumberger, M, 2002) |
| "After cTACE in patients with hepatocellular carcinoma (HCC), the presence of a viable tumor correlated with enhancement scores based on the density measurements of iodine depositions in different phases of the CT scan." | 3.96 | Measuring the density of iodine depositions: Detecting an invisible residual tumor after conventional transarterial chemoembolization. ( Buechter, M; Haubold, J; Li, Y; Ludwig, JM; Theysohn, JM; Umutlu, L; Wetter, A, 2020) |
| "The iodine concentration was calculated and compared with known true iodine concentration." | 1.39 | Iodine quantification with dual-energy CT: phantom study and preliminary experience with VX2 residual tumour in rabbits after radiofrequency ablation. ( Li, Y; Shi, G; Wang, S; Wu, R, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haubold, J | 1 |
| Ludwig, JM | 1 |
| Li, Y | 2 |
| Buechter, M | 1 |
| Wetter, A | 1 |
| Umutlu, L | 1 |
| Theysohn, JM | 1 |
| Lee, Y | 1 |
| Seo, HS | 1 |
| Je, BK | 1 |
| Kim, SD | 1 |
| Oh, HE | 1 |
| Shi, G | 1 |
| Wang, S | 2 |
| Wu, R | 1 |
| Klain, M | 1 |
| Ricard, M | 1 |
| Leboulleux, S | 1 |
| Baudin, E | 1 |
| Schlumberger, M | 1 |
| Bal, CS | 1 |
| Padhy, AK | 1 |
| Kumar, A | 1 |
1 review available for iodine and Minimal Disease, Residual
| Article | Year |
|---|---|
Radioiodine therapy for papillary and follicular thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Papillary; Clinical Trials as Topic; Combined Modality | 2002 |
4 other studies available for iodine and Minimal Disease, Residual
| Article | Year |
|---|---|
Measuring the density of iodine depositions: Detecting an invisible residual tumor after conventional transarterial chemoembolization.
Topics: Angiography; Arteries; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Et | 2020 |
Benefit of dual-energy CT iodine overlay technique for T1-hyperintense brain lesion.
Topics: Brain; Brain Neoplasms; Female; Glioblastoma; Humans; Iodine; Magnetic Resonance Imaging; Middle Age | 2017 |
Iodine quantification with dual-energy CT: phantom study and preliminary experience with VX2 residual tumour in rabbits after radiofrequency ablation.
Topics: Animals; Catheter Ablation; Disease Models, Animal; Female; Iodine; Liver Neoplasms, Experimental; N | 2013 |
Clinical features of differentiated thyroid carcinoma in children and adolescents from a sub-Himalayan iodine-deficient endemic zone.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Age Distribution; Bone Neoplasms; Carcinoma, Papillar | 2001 |